Cervical sample from the junction of the ectocervix and the endocervix (transition zone) in Surepath Liquid-Based Pap Test Preservative fluid OR Thinprep Pap Test PreservCyt® fluid.
Target Capture, TMA: Transcription-Mediated Amplification (NAT) and Dual Kinetic Assay (DKA). All specimens testing positive in the screening assay are confirmed in a confirmatory assay targeting different regions of the nucleic acid of the organism. This assay has been cleared for use by the FDA on some specimen types. For other specimen types where this assay has not been cleared or approved by the FDA; Pathology, Inc. has validated this test and determined its performance characteristics. This individual validation has not been cleared nor approved by the FDA.
See Appendix, Gynecologic Cytopathology Specimen Collection
As an aid in the diagnosis of Neisseria gonorrhoeae infection.